Post Hoc Analysis of Responses to Ponatinib in Patients With ChronicPhase Chronic Myeloid Leukemia (CPCML) by Baseline BCR::ABL1 Level and Baseline Mutation Status in the OPTIC Trial

Blood(2022)

引用 3|浏览3
暂无评分
关键词
CML,leukemia,ponatinib,TKI,T315I
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要